A third-generation, long-acting, dihydropyridine calcium antagonist, azelnidipine, attenuates stent-associated neointimal formation in non-human primates. (Q51144525)
Jump to navigation
Jump to search
scientific article published in September 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A third-generation, long-acting, dihydropyridine calcium antagonist, azelnidipine, attenuates stent-associated neointimal formation in non-human primates. |
scientific article published in September 2006 |
Statements
A third-generation, long-acting, dihydropyridine calcium antagonist, azelnidipine, attenuates stent-associated neointimal formation in non-human primates. (English)
1 reference
Kaku Nakano
1 reference
Kensuke Egashira
1 reference
Hideo Tada
1 reference
Yoshiro Kohjimoto
1 reference
Yasuhiko Hirouchi
1 reference
Shun-ichi Kitajima
1 reference
Yasuhisa Endo
1 reference
Xiao-Hang Li
1 reference
Kenji Sunagawa
1 reference
1 September 2006
1 reference
24
1 reference
9
1 reference
1881-1889
1 reference